Both semaglutide and tirzepatide are GLP-1 receptor agonists. A GLP-1 receptor agonist is released by your gut after you eat. It tells your brain that you’re full. Semaglutide mimics the GLP-1 receptor agonist. Tirzepatide also does that too, but it also targets the GIP receptor agonist, which stimulates insulin secretion.
Frisco Body Contouring will conduct tests to help determine which is right for you.